Abbott Whistleblower Seeks New Trial In $219M Stent Row
By Y. Peter Kang · May 6, 2016, 10:49 PM EDT
The whistleblower who accused Abbott Laboratories of improperly marketing bile duct stents for off-label use asked a Texas federal judge Friday to grant a new trial after a jury in April...
To view the full article, register now.